GINA recommendations in adults with symptomatic mild asthma and a smoking history

The Global Initiative for Asthma (GINA) 2019 report makes a major change in asthma management by recommending that adults and adolescents with mild symptomatic asthma (Step 1) receive as-needed low-dose inhaled corticosteroid (ICS)–formoterol rather than a short-acting β2-agonist alone [1]. At step 2, daily low-dose ICS is recommended, and GINA 2019 considers low-dose ICS–formoterol reliever as an alternative "preferred controller".

Source: European Respiratory Journal - February 5, 2020 Category: Respiratory Medicine Authors: Thomson, N. C., Chaudhuri, R. Tags: Original Articles: Correspondence Source Type: research